This website uses cookies

We use cookies to improve our services. Read more about how we use cookies and how you can refuse them.

The provision of clean injecting equipment is not very common in Europe, with the existence of syringe programmes in this setting reported by 5 countries, only 3 of which report the intervention’s actual implementation.



A recent announcement of the planned PNSP in 2 prisons in Canada is supported by an article to build support on developing harm reduction services in prison settings.

Federal government to uphold its commitment to a 'comprehensive, collaborative, compassionate and evidence-based approach to drug policy' (Government of Canada 2016), which includes harm reduction, by implementing PNSPs in consultation with correctional staff and people in prison. See more here.

See also:
(1) EMCDDA European drug report 2018,
(2)  Public health guidance on active case finding of communicable diseases in prison settings